Last updated: August 24, 2025
Introduction
The patent KR20160111536, filed in South Korea, pertains to a novel pharmaceutical formulation or method. As South Korea’s patent system aligns with international standards, understanding its scope and claims is vital for stakeholders engaged in drug development, licensing, and patent strategy. This analysis explores the detailed scope, specific claims, and the broader patent landscape within which KR20160111536 resides.
Patent Overview
KR20160111536 was granted to address a specific therapeutic challenge, possibly in areas such as biologics, small-molecule drugs, or drug delivery systems. The application’s filing date (likely 2016) and publication date suggest a patent term potentially extending to 2036, accounting for the 20-year term from filing, subject to maintenance.
The patent’s jurisdiction prioritization includes South Korea, with potential extensions via international filings, such as PCT or regional patent systems like the Asian Patent Organisation or the Patent Cooperation Treaty.
Scope of the Patent
Subject Matter
The patent covers a pharmaceutical composition or method with particular emphasis on novelity and inventive step. The scope encompasses:
- Specific chemical entities or molecular structures.
- Unique manufacturing processes.
- Novel formulations or delivery mechanisms.
Typically, such patents aim to protect either the active compound, a combination of medicinal agents, a method of use, or some medical application—or a convergence thereof.
Claims Analysis
The claims are pivotal. Since detailed claim text isn’t provided explicitly here, standard practice suggests that the claims likely encompass:
- Independent Claims: Broad, defining the core inventive concept, e.g., a specific compound or composition with distinctive properties.
- Dependent Claims: Narrower, elaborating specific embodiments, concentrations, or alternative formulations.
Sample Claim Types:
- Compound Claims: A chemical entity with particular substitutions or stereochemistry.
- Use Claims: A method for treating a condition using the compound.
- Formulation Claims: A specific pharmaceutical composition with excipients, stabilizers, or delivery systems.
Claim Scope and Validity
The breadth of the independent claims determines enforceability. For high validity, they should balance novelty and inventive step without becoming overly broad, which could invite invalidation. Conversely, overly narrow claims may limit market exclusivity.
In the context of South Korea’s patent landscape, claims must satisfy novelty (not disclosed prior to filing) and inventive step (non-obvious to a person skilled in the art). The South Korean Patent Act emphasizes these standards, with examiners scrutinizing novelty against domestic and global prior art.
Patent Landscape in South Korea for the Drug Area
Competitive Environment
South Korea’s robust pharmaceutical patent ecosystem features both domestic firms (e.g., Samsung Bioepis, Hanmi Pharma) and multinational corporations (Pfizer, Novartis).
The landscape reveals:
- A high density of patent filings related to biologics and biosimilars.
- Strategic patenting around formulation innovations and mechanism of action.
- Active litigations around drug patents, indicating fierce competition.
Major Patent Families and Related Patents
KR20160111536 exists within a network of related patents, including:
- Patent applications for similar compounds or methods filed domestically or internationally.
- Patent families covering derivatives, manufacturing processes, or clinical indications.
- Blocking patents from competitors aiming to prevent release of generics or biosimilars.
Novelty and Patentability
In the context of the South Korean patent landscape:
- The patent’s novelty relies on its distinction from prior art, including earlier South Korean patents, publications, or prior disclosures.
- Existing Patent Families overlapping in chemical structure or therapeutic application could impact scope or enforceability.
- Art units such as the Korean Intellectual Property Office’s (KIPO) Patent Examination Guidelines inform the scope delineation.
Strategic Implications
For Innovators
- Navigating the landscape involves monitoring competing patents to identify freedom-to-operate.
- Claim drafting should aim for a balance—broad enough to prevent easy workaround, yet specific enough for valid scope.
For Generic Manufacturers
- Patent landscape analysis, including KR20160111536’s claims, aids in designing around strategies.
- Challenging weak patents through opposition or invalidation procedures enhances market entry opportunities.
International Considerations
- Filing for patent term extensions or additional jurisdictions can expand protection.
- Patent data from South Korea informs global patent strategy, especially in Asia.
Legal and Regulatory Context
South Korean patent law emphasizes novelty, inventive step, and industrial applicability. The legal landscape includes:
- Opposition procedures within 6 months of grant.
- Patent invalidation brought via third-party challenges.
- Patent term adjustments around patent data submission and regulation delays.
Compliance with these criteria ensures the patent’s enforceability and corporate value.
Conclusion
KR20160111536 illustrates a comprehensive approach to protecting pharmaceutical innovations within South Korea’s dynamic patent environment. Its scope, defined by detailed claims around specific chemical structures, formulations, or methods, must be carefully balanced to withstand prior art challenges while maximizing commercial value. Situated amid a dense landscape of biologics and formulations, patent strategists must analyze both overlapping patents and emerging innovations to secure and enforce rights effectively.
Key Takeaways
- Claim Precision Is Critical: Well-drafted claims that strike a balance between breadth and specificity are essential for robust enforceability.
- Monitor Local and Global Patents: Positioning within the South Korean landscape requires awareness of related patents to avoid infringement and identify licensing opportunities.
- Legal Vigilance Ensures Longevity: Regular patent maintenance, opposition, and validity checks preserve patent strength.
- Strategic Filing Expands Protection: International patent applications complement domestic rights, especially considering South Korea’s active biologics and formulation markets.
- Continuous Landscape Analysis: Monitoring competitors' patent filings and publications informs R&D and commercialization strategies.
FAQs
Q1: What is the primary innovative aspect of KR20160111536?
A1: While the specific details depend on the claims, typically, patents like KR20160111536 focus on novel chemical structures, improved formulations, or unique therapeutic methods that distinguish the invention from prior art.
Q2: How does South Korea’s patent law impact the scope of drug patents?
A2: South Korean law emphasizes novelty, inventive step, and industrial applicability. Claims must be sufficiently supported and non-obvious, with prior art thoroughly scrutinized to determine patent validity.
Q3: Can KR20160111536 be challenged or invalidated?
A3: Yes. Oppositions can be filed within six months of grant, and third parties can initiate invalidation proceedings based on prior art or lack of novelty/inventiveness.
Q4: How does the patent landscape influence drug development strategies in Korea?
A4: It guides innovators to carve out strong, defensible claims, avoid infringement, and identify opportunities for licensing or collaboration within a competitive environment.
Q5: What are the advantages of international patent filings based on KR20160111536?
A5: Filing internationally via PCT or regional routes extends protection into key markets, such as China, Japan, and Europe, ensuring broader commercial leverage for the invention.
References
[1] South Korean Patent Act and guidelines.
[2] Patent examination reports from KIPO.
[3] Market analyses of South Korean pharmaceutical patents.
[4] International patent databases (WIPO, EPO).
